The Latest Breaking News from Lung Cancer

Merck and Daiichi Withdraw Small Cell Lung Cancer Drug Bid After FDA Signals Phase 2 Data Fell Short

Merck and Daiichi pulled their bid for accelerated approval of I-DXd in small-cell lung cancer after FDA feedback. What patients should ask now.

Medical Daily · 6h ago

First Phase 3 Trial Links Radiosurgery to Longer Survival When Small Cell Lung Cancer Spreads to the Brain

A phase 3 trial linked radiosurgery to longer survival in small-cell lung cancer that spread to the brain, but only as a secondary finding.

Medical Daily · 7h ago

Scots in most deprived areas 28 per cent more likely to develop cancer, study shows

Scots living in the country’s most deprived areas are 28 per cent more likely to develop cancer than people in the least deprived postcodes, new…

The National (Scotland) · Sep 27

Ivonescimab Topped Keytruda on Median Lung Cancer Survival by Eight Months in China but Lacks U.S. Approval

Ivonescimab beat Keytruda on survival in a China-only lung cancer trial, but the drug is not approved in the U.S. Here is what patients should know.

Medical Daily · Sep 17

First-Line Enhertu Delayed HER2-Mutant Lung Cancer Progression by Six Months Over Keytruda Plus Chemotherapy, but Survival Remains Unsettled

Enhertu delayed HER2-mutant lung cancer progression by a median of six months versus Keytruda plus chemo in a Phase 3 trial. Survival is unresolved.

Medical Daily · Sep 17

FDA Cuts Monitoring After Imdelltra's First Two Doses to Six to Eight Hours for Small Cell Lung Cancer

FDA cut monitoring after Imdelltra's first two doses from 22 to 24 hours to 6 to 8 hours, which may bring treatment closer to home for some patients.

Medical Daily · Sep 15

Gotistobart Nearly Doubled Median Survival Versus Chemotherapy in 87 Patient Lung Cancer Trial Stage, Pivotal Data Pending

Gotistobart reached 18.5 months median survival versus 10.0 months for chemotherapy in 87 previously treated squamous lung cancer patients. Pivotal data pending.

Medical Daily · Sep 14

5 Lung Conditions Indian Tailors, Carpenters and Stone Cutters Develop From Dust Exposure

Silicosis: The Stone Cutter's SentenceSilicosis is the most severe and irreversible lung condition found among Indian stone cutters, sandstone miners, and construction workers who grind or chisel silica-bearing rock. Fine crystalline silica particles, when inhaled repeatedly, lodge in the alveoli and trigger a fibrotic response: the lung tissue hardens around…

Times Life · Sep 13

Italy's Emma Bonino, champion of battles to legalise abortion and divorce, dies at 78

Veteran feminist activist Emma Bonino, who rose to political prominence in the 1970s as a leader of campaigns to legalise abortion and divorce in heavily Roman Catholic Italy over the objections of the Vatican, has died aged 78. Bonino, who was diagnosed with lung cancer in 2015, served as foreign…

France 24 · Sep 11

Lung Cancer Patients With HER2 Mutations Can Now Start a Daily Targeted Pill Before Any Other Systemic Treatment

The FDA expanded sevabertinib, sold as Hyrnuo, to first-line use for HER2-mutant lung cancer. Who qualifies, trial results, and key side effects.

Medical Daily · Sep 11